Literature DB >> 9633818

Mutations of the cationic trypsinogen in hereditary pancreatitis.

N Teich1, J Mössner, V Keim.   

Abstract

Hereditary pancreatitis (OMIM 167800) is thought to be associated with a mutation of the exon 3 of cationic trypsinogen (Nature Genet (1996): 14:141-145). This paper reports sequence data of two independent families suffering from this disease. PCR amplificates from leukocyte or buccal swab DNA showed no mutation of exon 3 of cationic trypsinogen. Instead, in exon 2, an A-to-T tranversion was found that led to the substitution of Asn by Ile in the sixth amino acid of the active trypsin. In exons 4 and 5, silent mutations were found. In the other expressed trypsinogens, several homozygous alterations not associated to hereditary pancreatitis were identified. As a model of pathogenesis, we hypothesize that mutation of trypsinogen in exon 2 could lead to premature cleavage of the activation peptide of trypsinogen or to altered intracellular transport.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9633818     DOI: 10.1002/(SICI)1098-1004(1998)12:1<39::AID-HUMU6>3.0.CO;2-P

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  19 in total

Review 1.  Hereditary pancreatitis: new insights into acute and chronic pancreatitis.

Authors:  D C Whitcomb
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

2.  Expression and penetrance of the hereditary pancreatitis phenotype in monozygotic twins.

Authors:  S T Amann; L K Gates; C E Aston; A Pandya; D C Whitcomb
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

Review 3.  Biochemical models of hereditary pancreatitis.

Authors:  Miklós Sahin-Tóth
Journal:  Endocrinol Metab Clin North Am       Date:  2006-06       Impact factor: 4.741

Review 4.  Mutations of human cationic trypsinogen (PRSS1) and chronic pancreatitis.

Authors:  Niels Teich; Jonas Rosendahl; Miklós Tóth; Joachim Mössner; Miklós Sahin-Tóth
Journal:  Hum Mutat       Date:  2006-08       Impact factor: 4.878

Review 5.  Human cationic trypsinogen (PRSS1) variants and chronic pancreatitis.

Authors:  Balázs Csaba Németh; Miklós Sahin-Tóth
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-01-23       Impact factor: 4.052

Review 6.  The role of trypsin, trypsin inhibitor, and trypsin receptor in the onset and aggravation of pancreatitis.

Authors:  Masahiko Hirota; Masaki Ohmuraya; Hideo Baba
Journal:  J Gastroenterol       Date:  2006-09       Impact factor: 7.527

7.  Hereditary pancreatitis and mutation of the trypsinogen gene.

Authors:  P Weber; V Keim; K P Zimmer
Journal:  Arch Dis Child       Date:  1999-05       Impact factor: 3.791

8.  [Clinical implications of genetic risk factors of chronic pancreatitis].

Authors:  N Teich; V Keim; J Mössner
Journal:  Internist (Berl)       Date:  2005-02       Impact factor: 0.743

Review 9.  [Therapy of chronic pancreatitis].

Authors:  J Mössner; V Keim
Journal:  Internist (Berl)       Date:  2003-12       Impact factor: 0.743

10.  The histopathology of PRSS1 hereditary pancreatitis.

Authors:  Aatur D Singhi; Reetesh K Pai; Jeffrey A Kant; Tanner L Bartholow; Herbert J Zeh; Kenneth K Lee; Martin Wijkstrom; Dhiraj Yadav; Rita Bottino; Randall E Brand; Jennifer S Chennat; Mark E Lowe; Georgios I Papachristou; Adam Slivka; David C Whitcomb; Abhinav Humar
Journal:  Am J Surg Pathol       Date:  2014-03       Impact factor: 6.394

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.